Picture of CorVel logo

CRVL CorVel Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for CorVel, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue592553646719795
Cost of Revenue
Gross Profit126124152158172
Selling / General / Administrative Expenses
Total Operating Expenses532493562634700
Operating Profit60.759.284.584.695.1
Net Income Before Taxes60.759.284.584.695.1
Provision for Income Taxes
Net Income After Taxes47.446.466.466.476.3
Net Income Before Extraordinary Items
Extraordinary Items
Net Income47.446.466.466.476.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income47.446.466.466.476.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.552.553.663.774.4